Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases.

Pharmaceutics · 2023 · PMC10384784 · PMID 37514117

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

VLPs are classified as self-assembling protein-based nanoparticles with a size range of 20–200 nm, rendering them capable of crossing the BBB, which is highly significant in the treatment of CNS diseases [ 96 , 97 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.